These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10491215)

  • 1. Growth retardation in children with chronic renal failure.
    Kuizon BD; Salusky IB
    J Bone Miner Res; 1999 Oct; 14(10):1680-90. PubMed ID: 10491215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Growth and renal function].
    Antoniazzi F; Mengarda F; Lauriola S; Serra A; Zamboni G; Tatò L
    Pediatr Med Chir; 1997; 19(5):341-7. PubMed ID: 9493225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth and nutrition of children with chronic renal failure.
    Stefanidis CJ
    Turk J Pediatr; 2005; 47 Suppl():9-12. PubMed ID: 15884661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism.
    Sanchez CP; He YZ
    J Am Soc Nephrol; 2005 Apr; 16(4):929-38. PubMed ID: 15728789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of PTH/PTHrP receptor in the kidney of patients with renal impairment.
    Chen J; Zhang J; Lin S
    Chin Med J (Engl); 1998 Jan; 111(1):24-7. PubMed ID: 10322647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of endochondral bone formation: roles of growth hormone, 1,25-dihydroxyvitamin D and hyperparathyroidism.
    Sanchez CP
    Pediatr Nephrol; 2000 Jul; 14(7):646-9. PubMed ID: 10912535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol.
    Sanchez CP; Salusky IB; Kuizon BD; Abdella P; Jüppner H; Goodman WG
    Kidney Int; 1998 Dec; 54(6):1879-87. PubMed ID: 9853253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic mechanisms underlying the variable response to recombinant human growth hormone in children with chronic renal failure.
    Schaefer F
    Br J Clin Pract Suppl; 1996 Aug; 85():23-5. PubMed ID: 8995024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone disease in patients receiving growth hormone.
    Watkins SL
    Kidney Int Suppl; 1996 Jan; 53():S126-7. PubMed ID: 8771006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis strategies to improve growth in children with chronic kidney disease.
    Fischbach M; Fothergill H; Seuge L; Zaloszyc A
    J Ren Nutr; 2011 Jan; 21(1):43-6. PubMed ID: 21195918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal statural growth in 2 infants on chronic peritoneal dialysis: anecdotal or whole management-related.
    Fischbach M; Terzic J; Menouer S; Provot E; Laugel V
    Clin Nephrol; 2001 Dec; 56(6):S17-20. PubMed ID: 11770806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormones regulate hypertrophic chondrocyte differentiation and expression of parathyroid hormone-related peptide and its receptor during endochondral bone formation.
    Stevens DA; Hasserjian RP; Robson H; Siebler T; Shalet SM; Williams GR
    J Bone Miner Res; 2000 Dec; 15(12):2431-42. PubMed ID: 11127207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal mRNA of PTH-PTHrP receptor, [Ca2+]i and phosphaturic response to PTH in phosphate depletion.
    Marcinkowski W; Smogorzewski M; Zhang G; Ni Z; Kedes L; Massry SG
    Miner Electrolyte Metab; 1997; 23(1):48-57. PubMed ID: 9058370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development.
    Amizuka N; Karaplis AC; Henderson JE; Warshawsky H; Lipman ML; Matsuki Y; Ejiri S; Tanaka M; Izumi N; Ozawa H; Goltzman D
    Dev Biol; 1996 Apr; 175(1):166-76. PubMed ID: 8608863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with recombinant human growth hormone (rhGH) in children with chronic kidney failure or renal transplantation].
    Crosnier H; Guest G; Souberbielle JC; Broyer M; Rappaport R
    Arch Pediatr; 1994 Aug; 1(8):716-22. PubMed ID: 7842104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone.
    Iwasaki-Ishizuka Y; Yamato H; Nii-Kono T; Kurokawa K; Fukagawa M
    Nephrol Dial Transplant; 2005 Sep; 20(9):1904-11. PubMed ID: 15985520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for recombinant growth hormone (rhGH) treatment in kidney diseases].
    Colombo D; Ghio L; Marchesi F; Giani M; Carcano A; Consalvo G; Edefonti A
    Pediatr Med Chir; 1995; 17(1):17-22. PubMed ID: 7739921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional management of the child with mild to moderate chronic renal failure.
    Sedman A; Friedman A; Boineau F; Strife CF; Fine R
    J Pediatr; 1996 Aug; 129(2):s13-8. PubMed ID: 8765644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.